C. Dittrich

A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV

Simone Steinbild, K. Mross, Annette Frost et al. · British Journal of Cancer · 2007 · 101 citations · Full text

Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial

Ulrich Jaeger, Marek Trněný, Helen Melzer et al. · Haematologica · 2015 · 83 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Rituximab Maintenance Therapy +14

Early results from a phase I study on orally administered tris(8-quinolinolato)gallium(III) (FFC11, KP46) in patients with solid tumors ? a CESAR study (Central European Society for Anticancer Drug Research ? EW

Ralf‐Dieter Hofheinz, C. Dittrich, Michael A. Jakupec et al. · International Journal of Clinical Pharmacology and Therapeutics · 2005 · 61 citations

Medicinal Chemistry, Cesar Study, Medicine +11

European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 60-minute infusion every 3 weeks in recurrent glioblastoma multiforme

Martin J. van den Bent, Wolfgang Grisold, Didier Frappaz et al. · Annals of Oncology · 2003 · 42 citations · Full text

Neuro-oncology, Glioma, Medicine +12

Genes related to growth and invasiveness are repressed by sodium butyrate in ovarian carcinoma cells

Georg Krupitza, Susan P. Grill, Hanna Harant et al. · British Journal of Cancer · 1996 · 37 citations · Full text

Developmental Biology, Oncogenic Agent, Medicine +9